Thu, May 3, 2018
Wed, May 2, 2018
Tue, May 1, 2018
Mon, April 30, 2018
Fri, April 27, 2018
Thu, April 26, 2018
Wed, April 25, 2018
Tue, April 24, 2018
Mon, April 23, 2018

Vamil Divan Maintained (ABBV) at Hold with Decreased Target to $104 on, Apr 27th, 2018


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-104-on-apr-27th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Vamil Divan of Credit Suisse, Maintained "AbbVie Inc." (ABBV) at Hold with Decreased Target from $109 to $104 on, Apr 27th, 2018.

Vamil has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018
  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018


These are the ratings of the 2 analyists that currently disagree with Vamil


  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $80 on, Friday, March 23rd, 2018
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $145 on, Friday, February 2nd, 2018

Publication Contributing Sources